Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma
Phase 2 Terminated
4 enrolled 11 charts
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)
Phase 2 Terminated
59 enrolled 18 charts
COCHISE
Phase 2 Terminated
18 enrolled 9 charts
A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal Cancer
Phase 2 Terminated
16 enrolled 29 charts
A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors
Phase 1/2 Terminated
5 enrolled 9 charts
APK Mutant
Phase 2 Terminated
7 enrolled 15 charts
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
Phase 1/2 Terminated
2 enrolled 13 charts
MODULATE
Phase 1/2 Terminated
2 enrolled 7 charts
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
Phase 1/2 Terminated
4 enrolled 14 charts
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Terminated
22 enrolled 5 charts
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Phase 3 Terminated
1,333 enrolled 22 charts
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Phase 2 Terminated
30 enrolled 17 charts
Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE)
Phase 2 Terminated
3 enrolled 6 charts
Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
Phase 1/2 Terminated
13 enrolled 6 charts
Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
Phase 2 Terminated
23 enrolled 8 charts
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation
Phase 1/2 Terminated
5 enrolled 9 charts
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer
Phase NA Terminated
8 enrolled 9 charts
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase NA Terminated
3 enrolled 8 charts
Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)
Phase 2 Terminated
23 enrolled 18 charts
EXTAX
Phase 2 Terminated
17 enrolled 8 charts
A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Phase 1/2 Terminated
179 enrolled 38 charts
Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer
Phase 2 Terminated
7 enrolled 5 charts
Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Phase 2 Terminated
50 enrolled 9 charts
MK-0646-025
Phase 2 Terminated
11 enrolled 8 charts
Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
Phase 1/2 Terminated
3 enrolled 7 charts
Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
Phase 2 Terminated
6 enrolled 7 charts
PembroMab
Phase 1/2 Terminated
16 enrolled 6 charts
Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery
Phase 2 Terminated
8 enrolled 16 charts
Dasatinib
Phase 1 Terminated
22 enrolled 8 charts
Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
Phase 2 Terminated
13 enrolled 9 charts
A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer
Phase 2 Terminated
19 enrolled 32 charts
Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )
Phase 2 Terminated
87 enrolled 13 charts
Individualized Drug Treatment for Treating Patients With Pancreatic Cancer
Phase 2 Terminated
249 enrolled 4 charts
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
Phase 1/2 Terminated
15 enrolled 11 charts
RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN
Phase 1/2 Terminated
9 enrolled 9 charts
FC-4
Phase 2 Terminated
4 enrolled 9 charts
Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab
Phase 2 Terminated
10 enrolled 8 charts
Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Phase 2 Terminated
21 enrolled 8 charts
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
Phase 1/2 Terminated
23 enrolled 18 charts
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
Phase 2 Terminated
7 enrolled 6 charts
Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
Phase 1/2 Terminated
29 enrolled 13 charts
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer
Phase 2 Terminated
16 enrolled 5 charts
Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC
Phase 2 Terminated
18 enrolled 7 charts
Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma
Phase 2 Terminated
5 enrolled 9 charts
Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement
Phase 2 Terminated
9 enrolled 12 charts
Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer
Phase NA Terminated
2 enrolled 6 charts
A Study of Mitomycin C, Irinotecan, and Cetuximab
Phase 2 Terminated
13 enrolled 5 charts
Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)
Phase 2 Terminated
4 enrolled 5 charts
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Phase 2 Terminated
22 enrolled 9 charts
Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan
Phase 2 Terminated
20 enrolled 8 charts